STAT3 and neoplasm: Altogether, STAT3 and its downstream target genes not only promote proliferation (Cyclin D1, c-Myc), survival (Bcl-2, survivin, Bcl-xL), angiogenesis (VEGF, HIF1α), and metastasis (MMPs), but also inhibit anti-tumor immune responses [3,34].